The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biomedical and environmental sciences : BES

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3967/0895-3988.2012.01.007PMID 22424626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

  2010cited by this paper
• Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

  2009cited by this paper
• Diastolic heart failure: mechanisms and controversies

  2008cited by this paper
• Implications of polycystic ovary syndrome on oocyte development.

  2008cited by this paper
• Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell‐to‐cell interaction and transition

  2008cited by this paper
• The mare model for follicular maturation and reproductive aging in the woman.

  2008cited by this paper
• Pharmacogenomics of metabolic effects of rosiglitazone.

  2008cited by this paper
• Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis

  2008cited by this paper
• Transforming growth factor-beta and fibrosis.

  2007cited by this paper
• Treatment targets in renal fibrosis.

  2007cited by this paper
• Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF‐β1 to induce mesenchymal cell condensation

  2007cited by this paper
• Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.

  2007cited by this paper
• Transforming growth factor-β and fibrosis

  2007cited by this paper
• Elevated serum levels of matrix metalloproteinase‐2 in women with polycystic ovarian syndrome

  2007cited by this paper
• Mécanismes de la fibrogenèse pulmonaire.

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.

  2006cited by this paper
• The role of transforming growth factor-β in atherosclerosis

  2006cited by this paper
• Thiazolidinediones for initial treatment of type 2 diabetes?

  2006cited by this paper
• The role of transforming growth factor-beta in atherosclerosis.

  2006cited by this paper
• MMPS and TIMPS in ovarian physiology and pathophysiology.

  2004cited by this paper
• Extracellular matrix of the developing ovarian follicle.

  2003cited by this paper

• Androgen dysregulates the follicular extracellular matrix and increases pro-fibrotic gene expression in the mouse ovary.

  2026cites this paper
• LncPrep + 96kb inhibits ovarian fibrosis by upregulating prolyl oligopeptidase expression

  2025cites this paper
• Molecular mechanisms of ovarian fibrosis

  2025cites this paper
• Extracellular matrix dysregulation in PCOS: pathogenesis, therapeutic strategies, and innovative technologies

  2025cites this paper
• The influence of CCN family proteins on ovarian physiology and pathology.

  2025cites this paper
• Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole‐induced polycystic ovary syndrome SD rats

  2024cites this paper
• IL-18BP Therapy Ameliorates Reproductive and Metabolic Phenotypes in a PCOS Mouse Model by Relieving Inflammation, Fibrosis and Endoplasmic Reticulum Stress

  2024cites this paper
• Ovarian fibrosis: molecular mechanisms and potential therapeutic targets

  2024cites this paper
• Shear wave elastography to assess stiffness of the human ovary and other reproductive tissues across the reproductive lifespan in health and disease

  2024cites this paper
• Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response

  2024cites this paper
• Expression and Clinical Significance of HIF-1α in Follicular Fluid and Granulosa Cells in Infertile PCOS Patients

  2023cites this paper
• Irpex lacteus polysaccharide exhibits therapeutic potential for ovarian fibrosis in PCOS rats via the TGF-β1/smad pathway

  2023influential citation
• Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology

  2023cites this paper
• Ovarian Stiffness Is Significantly Increased in Polycystic Ovary Syndrome and Related With Anti-Mullerian Hormone

  2022cites this paper
• PCOS Animal Models: An Approach Induced By Dehydroepiandrosterone

  2021cites this paper
• Adalimumab Increases Follicle Reserve and Follicle Development in Rat Ovary: The Effect of Adalimumab on Ovarian Reserve

  2020cites this paper
• Metformin Decreases the Expression of VEGF-A and CTGF-1 and Improves Histological, Ultrastructural and Hormonal Changes in Adult Rat Polycystic Ovary

  2019cites this paper
• Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study

  2019cites this paper
• Evaluation of the Rho A/Rho-kinase pathway in the uterus of the rat model of polycystic ovary syndrome.

  2019cites this paper
• Expression of FKBP52 in the ovaries of PCOS rats

  2018cites this paper
• DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway

  2018cites this paper
• Ovarian Fibrosis: A Phenomenon of Concern

  2017influential citation
• Hormone‐induced rat model of polycystic ovary syndrome: A systematic review

  2017cites this paper
• Activation of Endoplasmic Reticulum Stress in Granulosa Cells from Patients with Polycystic Ovary Syndrome Contributes to Ovarian Fibrosis

  2017cites this paper
• Dehydroepiandrosterone-Sulfate, Insulin Resistance and Ovarian Volume Estimation in Patients With Polycystic Ovarian Syndrome

  2017cites this paper
• A combination of stereological methods, biochemistry and electron microscopy for the investigation of drug treatment effects in experimental animals

  2016cites this paper
• Accumulation of organotins in seafood leads to reproductive tract abnormalities in female rats.

  2015cites this paper
• The Role of TGF-β in Polycystic Ovary Syndrome

  2014cites this paper
• Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

  2013cites this paper
• in Polycystic Ovary Syndrome β The Role of TGF -

  2013cites this paper